Background We tested the hypothesis that serum apolipoprotein H (apo H) concentration increases after an oral fat load. Such a study would give valuable insight into whether apo H was influenced by the postprandial state.
Introduction
Apolipoprotein H (apo H), also known as b 2 -glycoprotein I, is a single-chain glycoprotein consisting of 326 amino acid residues with a molecular weight of about 47 000 and is involved in clotting mechanisms. 1 The exact functions of apo H are unclear, although there is evidence that it inhibits platelet prothrombinase activity as well as ADP-induced platelet aggregation. 2, 3 In addition, apo H has been reported to be a co-factor for the binding of certain antiphospholipid antibodies (apA) to anionic phospholipids which can be de¢ned as lupus anticoagulant activity or a positive anticardiolipin immunoabsorbent assay. 4, 5 Apo H is an activator of lipoprotein lipase and is involved in lipoprotein metabolism, particularly of triglyceriderich lipoproteins. 6^10 It has been postulated that atherogenesis is a postprandial phenomenon. Indeed, it has been suggested that the duration and degree of postprandial lipaemia may be associated with the presence of atherogenic particles, including small dense LDL and chylomicron remnants. 11^14 We wished, therefore, to test the hypothesis that serum apo H concentration may be increased in the postprandial state as well as relate to parameters of lipid metabolism. Such a study would give valuable insight into whether serum apo H concentrations are in£uenced by oral fat intake and if it is implicated in postprandial lipid events.
Methods

Study individuals
Ten male subjects were studied. St Thomas' Hospital ethical committee approval was granted for the study and all subjects gave informed consent. Their ages were between 24 and 48 years and their baseline characteristics are given in Table 1 . None was on any medication at the time of the study or had known malignancy, in£ammatory disease, diabetes mellitus or had undergone recent surgery.
The individuals were asked to fast for 12-24 h overnight prior to the study, and were only allowed water. They were then fed 62.5 g of total fat (saturates 12 g, monounsaturates 35.3 g, polyunsaturates12.5 g) in the form of 150 mL of strawberry £avoured Calogen (SHS International Ltd, Liverpool, UK) which they drank within 5 min. This contained 675 kcal per 100 mL with negligible protein or carbohydrate content.
Blood was taken from an indwelling intravenous catheter, usually sited in the antecubital fossa, at 0, 180 and 300 min after the oral fat load. The methodology was similar to that used previously. 14 Samples were collected in £uoride anticoagulant for plasma glucose and without anticoagulant for serum assays of cholesterol, triglycerides, HDL-cholesterol, apo A1, apo B, apo H and insulin. Serum and plasma samples were immediately separated from erythrocytes and frozen at 7208C prior to analysis.
Supine arterial systolic blood pressure and diastolic blood pressure, after 5 min rest, were measured automatically using a sphygmomanometer (Abbey Surgical Ltd, Surrey, UK). Subject weight and height were recorded in indoor clothing but without shoes and the body mass index (BMI) calculated using the formula (weight in kg)/(height in m) 2 . Hip and waist girth were measured, using a tape measure by the same observer, at the maximum circumference at the level of the greater trochanter and half the distance between the lower rib margin and the level of the anterior iliac spine respectively. Body composition, including body fat mass and lean body mass, were measured by bioelectrical impedance analysis on a TBF-105 machine (Tanita Corporation, Japan).
Assays
The following analytes were measured on a Cobas Fara analyser (Roche, Lewes, UK). Serum apo H was measured immunoturbidimetrically using antisera against apo H obtained from Dade Behring (Milton Keynes, UK). The intra-assay coe⁄cient of variation (CV) was less than 7%. Freezing and then re-thawing did not signi¢cantly a¡ect apo H concentrations. Serum apo A1 and apo B were also assayed immunoturbidimetrically. Serum cholesterol and triglyceride were assayed enzymatically with reagents from Roche. Serum HDL-cholesterol was similarly measured in the supernatant after precipitation of other lipoproteins with dextran sulphate-manganese chloride reagent. Plasma glucose was assayed by the glucose oxidase method.
Serum insulin was assayed by a radioimmunoassay and had a minimal detection limit of 1mU/L and analytical range as determined by precision pro¢les of 2-200 mU/L. Radiolabelled material was supplied by Amersham International (Amersham, UK). The intraassay CV was less than 8% for all of these assays.
Statistics
Paired parametric data were compared using the paired t-test. For non-parametric data the Wilcoxon rank test was used. Statistical signi¢cance was taken as P50.05. Results are shown as the mean (standard deviation or range in parentheses if data were not normally distributed). Statistical correlation was assessed using the Pearson test. Logarithms (base 10) were taken for data that were not normally distributed (triglyceride and insulin). Analysis of serial measurements was performed using the method of area under the curve proposed by Matthews et al. 15 Insulin resistance index (IRI) was calculated from the following equation: (fasting serum insulin concentration)/22.5e7ln(fasting plasma glucose concentration). 16 Serum LDL-cholesterol was calculated by Friedewald's equation.
Results
Baseline clinical details of these individuals are depicted in Table 1 . Serum triglyceride concentration increased after an oral fat load peaking at 240 min. The serum triglyceride at baseline (0 min) was 1.29 (0.66) mmol/L versus 2.35 (1.44) mmol/L at 240 min (P50.01). There was, however, no signi¢cant change in serum apo H concentration following the oral fat load over the 300 min period (see Fig. 1 ). Table 2 and Fig. 2) .
In stepwise multiple linear regression model, with serum apo A1, apo B, lipoprotein(a), total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, plasma glucose and insulin and apo H as the dependent variable, insulin remained in the model (r ¼ 0.81, P50.01). Conversely, with BMI, body fat mass, lean body mass and waist/hip ratio in the model and apo H as dependent variable, only body fat mass remained in the model (r ¼ 0.78, P50.01).
Discussion
We have shown that our hypothesis, that serum concentrations of apo H may increase as a result of an oral fat load, was incorrect. This ¢nding agrees with the results of a previous study which showed that the serum concentrations of apo H in pre-and postprandial samples were not signi¢cantly di¡erent. 10 We have, however, observed positive correlations between serum apo H and fasting serum insulin, BMI and IRI in our non-diabetic individuals.We also found that serum apo H concentrations are not signi¢cantly related to blood pressure and waist/hip ratio. However, serum apo H concentrations did signi¢cantly correlate independently with body fat mass, suggesting the importance of di¡erent body adipose depots, as well as independently correlating with plasma insulin concentration. We would suggest that further studies are necessary to substantiate these observations in a larger cohort. It is worth noting, however, that Cassader et al. demonstrated elevated apo H concentrations in type 2 diabetic patients and that serum apo H concentration may relate to glycaemic control in these patients. 17 One could speculate that serum apo H is involved in insulin resistance states, given its correlation with serum triglyceride, BMI, fat mass, insulin concentrations and IRI. Elevated serum apo H has also been observed in hyperlipidaemic patients. 8, 17 Apo H is a component of circulating plasma lipoproteins and has a high a⁄nity for triglyceridecontaining particles. The serum apo H concentrations observed in this study are of the same magnitude as those found in other reports. 8, 9 These ¢ndings are also in keeping with previous ¢ndings by ourselves and others showing a relationship between plasma apo H and features of insulin resistance. 18, 19 Unlike other apolipoproteins, apo H does not selfassociate in aqueous solution and its secondary, tertiary and quaternary structures are di¡erent from those of most of the other apolipoproteins. 20 Apo H was not signi¢cantly related to apo A1 or apo B in our individuals. These ¢ndings are consistent with previous observations. 21 Mention should also be made of the genetic studies of apo H which have suggested the in£uence of apo H polymorphism upon serum lipids. 22^26 The apo H3 allele may be related to elevated serum triglyceride concentrations. 27 In conclusion, we report that serum apo H concentration is not in£uenced by an oral fat load. Using the same cohort we have previously reported that serum acute-phase proteins such as C-reactive protein also do not increase after an oral fat load. 28 Nevertheless, in this small study we have shown a signi¢cant correlation between fasting serum apo H concentration and subject BMI, body fat mass, serum insulin and triglyceride concentrations as well as IRI. This raises the possibility that apo H may be related to features of insulin resistance and adipose tissue metabolism; this needs to be further investigated in larger studies.
